GLAXOSMITHKLINE (GSK.L) Trading
Live Chart & Price Analysis
View the real-time GLAXOSMITHKLINE (GSK.L) quote and decide if you want to go long or short. Find insights, analysis, the latest news and other information to help you with your trading.
$1,810.96
-0.85%Followers
348
Annual change
15.28%
Daily price range:
Low
1,786.94
High
1,813.44
Trade GSK
CFD trading involves risk
GSK live price
Live Chart
Past performance is not a reliable indicator of future results.
Should you buy or sell GLAXOSMITHKLINE right now?
Based on NAGA Sentiment¹, 100.00% are buying GLAXOSMITHKLINE and 0.00% are selling GLAXOSMITHKLINE right now. However, opening a long or short position now depends on your risk tolerance, investment horizon, and GLAXOSMITHKLINE market outlook.
Selling
0.00%
100.00%
Buying
GLAXOSMITHKLINE price analysis
The price of GLAXOSMITHKLINE today, as of October 1, 2026, was $1810.96. That's down -1.70% from last session's GLAXOSMITHKLINE closing price. The GLAXOSMITHKLINE price is declining this week. Compared to last week, the rate of GLAXOSMITHKLINE is down -2.90%, and it's down -3.20% from one month ago.
The 52-week GLAXOSMITHKLINE price high is $2275.96, while the 52-week GLAXOSMITHKLINE price low is $1589.94.
Year to date, GLAXOSMITHKLINE price is up 13.50% from the beginning of the year and has had a return of 13.50% in the last 12 months.
Low$1786.94
Day's Range
Low$1589.94
52w Range+0.2%
1h
-1.7%
24h
-2.9%
7d
-3.3%
14d
-3.2%
30d
+13.5%
1y
GLAXOSMITHKLINE trading insights
The crowd feels POSITIVE about GLAXOSMITHKLINE, with a HIGH volume of news backing the POSITIVE sentiment score². At the start of today's GLAXOSMITHKLINE trading session, the sentiment signal³ is BULLISH, indicating whether the GLAXOSMITHKLINE price is more likely to increase or decrease today and in the following days.
The level of news⁴ backing the sentiment score is HIGH, indicating how confident the markets are to buy GLAXOSMITHKLINE right now. The LOW subjectivity⁵ indicates that the GLAXOSMITHKLINE price is UNDERVALUED.
Sentiment Signal
Bullish
Next update: Oct 2, 06:00
Sentiment Score
Positive
58 / 100
Subjectivity
Low Subjectivity
14 / 100
Confidence Index
High
Discover key GLAXOSMITHKLINE trends with NAGA Insights
What am I Missing?
Make informed decisions based on real-time data, expert analysis, and powerful research tools from TipRanks.
Access advanced GLAXOSMITHKLINE charting, technical analysis, and live market data from TradingView.
Get AI-powered GLAXOSMITHKLINE trade signals, in-depth market analysis, and technical strategy insights from Trading Central.
CFD trading involves risk
How to trade GLAXOSMITHKLINE with leverage?
Trade GLAXOSMITHKLINE if you want flexibility to speculate on its price movements in both directions. With CFDs, you can open a buy position (go long) if you think the GLAXOSMITHKLINE price will rise, or you can open a sell position (go short) if you believe the GLAXOSMITHKLINE price will fall.
You won’t need to commit to the full value of the position (see the required margin below), but bear in mind that leverage can increase both your profits and losses.
If you want to speculate on GLAXOSMITHKLINE price, search for GLAXOSMITHKLINE CFD. Then click on the "GLAXOSMITHKLINE" symbol to view the chart and other insights before placing your trade. Also, review "GLAXOSMITHKLINE" contract specification to be aware of all the GLAXOSMITHKLINE CFD trading conditions.
trading conditions:
Platform
MT5
Platform spreads
Live: 0.1241
Ticker#GSK.L
Margin (%)*
Volume step
Lot value
Minimum trade size
Maximum trade size
Commission0.00%
Monthly price change (%)-0.85%
Annual price change (%)15.28%
Digits
Tick value0
Trading Hours & FeesCFD trading involves risk
About GLAXOSMITHKLINE
GSK
Glaxosmithkline
CFD
-0.85%
$1,821.56
$1,810.96
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development; two strategic collaborations with Relation to advance therapeutics for fibrotic diseases and osteoarthritis; and multi-target strategic alliance with GSK to develop breakthrough treatments for people afflicted with Parkinson's disease; as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.dom.
GLAXOSMITHKLINE price forecast, news, and analysis
Discover the latest news that can influence GLAXOSMITHKLINE’s earnings sentiment and GLAXOSMITHKLINE forecast and price predictions.
Neutral
Wave Life announces GSK’s selection of siRNA program to transition to GSK
30/09/2026/07:40
Positive
GSK retains ‘buy’ rating at Jefferies as B7H3 cancer programme seen as underappreciated
29/09/2026/07:30
FAQs about GLAXOSMITHKLINE trading
The price of GLAXOSMITHKLINE today, as of October 1, 2026, was 1810.96. That's down -1.70% from the previous session's GLAXOSMITHKLINE closing price.
IMPORTANT NOTICE: The content presented in the instrument page is only for informational, educational and support purposes. The material presented, including analyses, sentiment, consensus, prices, opinions or other content, is not an investment recommendation or information that recommends or suggests an investment strategy, nor is it included in the scope of investment advice. NAGA will not accept liability for any loss or damage, including but not limited to any loss of profits, that may arise directly or indirectly from the use of or reliance on the information contained in this page. NAGA is not responsible for the actions or omissions of the client, especially for the acquisition or disposal of financial instruments, made based on the information contained in this page. Past performance is not necessarily indicative of future results, and anyone acting on this information does so at their own risk. ¹ NAGA sentiment reflects the positions held by active NAGA users who currently maintain open trades in a specific instrument. This information is provided for indicative purposes only and should not be interpreted as investment advice or a recommendation to trade. ² ³ ⁴ ⁵ The sentiment dashboard is provided by Trading Central. Sentiment insights and market views are based on available data and do not guarantee future performance.
Need Help? Visit our Help Section
Download NAGA Trader
Download NAGA Trader
Click the QR code to enlarge
Copyright © 2026 – All rights reserved.
NAGA is a trademark of The NAGA Group AG, a German based FinTech company publicly listed on the Frankfurt Stock Exchange | WKN: A41YCM | ISIN: DE000A41YCM0.
The website is operated by JME Financial Services (Pty) Ltd an authorised Financial Services Provider, regulated by the Financial Sector Conduct Authority in South Africa under license no. 37166. JME Financial Services (Pty) Ltd is located at Suite 10, 21 Lighthouse Rd 201 Beacon Rock, Umhlanga Rocks, Kwa-Zulu Natal, 4320, South Africa.
JME Financial Services (Pty) Ltd acts as an intermediary between the investor and NAGA Capital Ltd, the counterparty to the contract for difference purchased by the Investor via Naga.com/za. NAGA Capital Ltd is authorised and regulated by the Financial Services Authority Seychelles (FSA) under licence No. SD026. NAGA Capital Ltd is the principal to the CFD purchased by investors on this website. Other group entities: NAGA Markets Europe LTD which is authorised and regulated by the Cyprus Securities and Exchange Commission (CySEC) under licence No. 204/13.
RISK WARNING: Derivatives are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how derivatives work and whether you can afford to take the high risk of losing your money. The value of financial products can increase as well as decrease over time, depending on the value of the underlying securities and market conditions. Illustrations, forecasts or hypothetical data are not guaranteed and are provided for illustrative purposes only. JME Financial Services (Pty) Ltd does not render advice in respect of the CFD’s offered on this website. Before making an investment decision, you should rely on your own assessment. The Company’s disclaimer, conflict of interest policy are available on legal documents section.